For more than 100 years, C. R. Bard, Inc. has been developing innovative medical devices that meet the needs of clinicians and their patients.
BARD has grown from a one-man operation in New York City in 1907 to a global company with 13,000 employees worldwide and business operations in 90 countries.
BARD has four divisions and more than 15,000 products in the disease areas of Vascular, Urology, Oncology, and Surgical Specialty. Our products range from devices that treat hernias, to stents that prevent blood clots from traveling to the lungs, catheters that reduce hospital-acquired infections, thermoregulatory devices designed to monitor and control a patient’s temperature, and ports that delivery chemotherapy reducing frequent needle sticks for children and adults.
For more information, please see the individual division websites